I drew the conclusion that RO was not performed on

I drew the conclusion that RO was not performed on all CD12 patients from discussions on this board.

It was completely stunning to me that CYDY would proceed with a trial and not conduct the proof-of-concept testing to verify the theory of Leronlimab in covid.

It was never clear to me how many of the CD12 patients were not tested.

It did seem clear to me that at least some of them were not tested for RO.

It did seem clear to me that it takes quite a long time to develop a CCR5 RO test, like at least two months, and that would mean a big chunk of CD12 patients were not tested if Patterson stopped and someone else needed to spin up.

But more importantly in my mind, even if a new CD12 test were developed, it could likely not be used as an apples-to-apples comparison with any Patterson tests conducted on any early CD12 patients that were tested.

Stoppage of CD12 RO testing just kills you in the event that the CD12 results are squishy, which turned out to exactly be the case.

For me, the saga of RO testing at Cytodyn on both HIV and CD12 is clear and compelling evidence of the incompetence of the Cytodyn management team.